RICHARD BONNEAU
VICE PRESIDENT OF MACHINE LEARNING FOR DRUG DISCOVERY, GENENTECH
"If you have a system that can show you hundreds of thousands of alternatives, where they all are likely to retain expression and binding in the other biophysical properties, then it allows you to search the space when you have a troublesome tryptophan or a problematic epitope ... or all these various persnickety problems that pop up and get you trapped in a local minima."